DOLLAR GENERAL ACNE SPOT MEDICATION
US over-the-counter (OTC) label
In the United States, these products are sold as over-the-counter (OTC) drugs: sunscreens, antiperspirants, anti-dandruff products, anticavity toothpastes, acne products and skin protectants. The label separates active and inactive ingredients. In the European Union, a product with a cosmetic purpose must comply with Regulation (EC) No 1223/2009. A filter or active allowed in the United States may not be authorised for that use in the EU. The classification depends on the purpose: a hand sanitiser may fall under biocides and an acne treatment under medicines. This analysis applies the cosmetic rules to the ingredients without establishing the compliance of the finished product. The formula sold in Europe under the same name may be different.
openFDA: US OTC product labels, analysed under European cosmetic rules, retrieved 16 November 2026.
Stated use in the United States
Use s for the treatment of acne
Published active ingredients
Purpose Salicylic Acid 2%............................................Acne medication
Published inactive ingredients
Alcohol, Butylene Glycol, Capryloyl Glycine, Cedrus Atlantic Bark Extract, Cinnamomum Zeylanicum Bark Extract, Hexylene Glycol, Hydroxyethylcellulose, Methylparaben, Portulica Oleracea Extract, PPG-2 Isoceth-20 Acetate, Propylene Glycol, Propylparaben, Sarcosine, Sodium Citrate, Water
openFDA: US OTC product labels, analysed under European cosmetic rules, retrieved 16 November 2026.
Cosmetic analysis in the European Union
4 ingredients allowed under conditions (maximum concentration, product types): some active ingredient concentrations are printed; the other conditions and the product's classification in the European Union remain to be checked. 15 names recognised out of 16.
Warning: 1 name out of 16 is not recognised (PPG-2 Isoceth-20 Acetate): nothing below covers it.
Spelling corrected, check it on the packaging: “Cedrus Atlantic Bark Extract” read as CEDRUS ATLANTICA BARK EXTRACT; “Portulica Oleracea Extract” read as PORTULACA OLERACEA EXTRACT.
- Pregnancy and breastfeeding : Worth watching SALICYLIC ACID
- Babies and children : Prohibition or serious classification SALICYLIC ACID, Worth watching PROPYLPARABEN
Salicylic Acid 2%, Alcohol, Butylene Glycol, Capryloyl Glycine, Cedrus Atlantic Bark Extract spelling corrected, Cinnamomum Zeylanicum Bark Extract, Hexylene Glycol, Hydroxyethylcellulose, Methylparaben, Portulica Oleracea Extract spelling corrected, PPG-2 Isoceth-20 Acetate, Propylene Glycol, Propylparaben, Sarcosine, Sodium Citrate, Water
Who it concerns
For each group, the ingredients of the list that an official classification or rule mentions. Open an ingredient's page to read what the text says. A group with no name does not mean the ingredients were judged to have no effect for it.
Prohibition or serious classificationThe text prohibits the substance for this use, or ranks it among the most serious hazards (known or presumed carcinogenic, mutagenic or reprotoxic, identified endocrine disruptor).Worth watchingThe text sets a condition or flags a hazard worth knowing: allergen, suspected effect, condition for children, hazard to the aquatic environment.For informationOfficial information with no condition on a finished product: warning to read, irritation of the pure substance.
Pregnancy and breastfeeding
- Worth watching SALICYLIC ACIDClassified under the CLP Regulation: reproductive toxicity, category 2 (Repr. 2), a hazard to the unborn child. The European Union nevertheless allows it under the conditions of its annex, after an opinion of its Scientific Committee on Consumer Safety (SCCS).
Babies and children
- Prohibition or serious classification SALICYLIC ACIDAnnex III, entry 98, prohibits it in products intended for children under 3: “Not to be used in preparations for children under 3 years of age.” Annex V, entry 3, prohibits it in products intended for children under 3: “Not to be used in products for children under 3 years of age.”
- Worth watching PROPYLPARABENAnnex V, entry 12 a, prohibits it for children under 3 in certain products only: “Not to be used in leave-on products designed for application on the nappy area of children under three years of age.”
Skin, eyes and allergies
- For information SALICYLIC ACIDClassified under the CLP Regulation: serious eye damage, category 1 (Eye Dam. 1). This classification describes the pure substance; in a finished product it is far more diluted.
- For information HEXYLENE GLYCOLClassified under the CLP Regulation: eye irritation, category 2 (Eye Irrit. 2); skin irritation, category 2 (Skin Irrit. 2). This classification describes the pure substance; in a finished product it is far more diluted.
Read on the label
- For information SALICYLIC ACIDAnnex III, entry 98, requires this to be printed on the pack: “(a) (b) (c) Not to be used for children under 3 years of age* * Solely for products which might be used for children under 3 years of age.”. Annex V, entry 3, requires this to be printed on the pack: “Salicylic acid: Not to be used for children under 3 years of age** **Solely for products which might be used for children under 3 years of age. Salicylic acid salts: Not to be used for children under 3 years of age*** ***Solely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.”.
- For information PROPYLPARABENAnnex V, entry 12 a, requires this to be printed on the pack: “For leave-on products designed for children under three years of age: "Do not use on the nappy area"”.
No official text covers the recognised ingredients for: environment.
For a question about your own situation (pregnancy, child, allergy), show this list to your doctor, midwife or pharmacist: we cannot say whether this product suits you.
Selling elsewhere
Ingredients of this list that are prohibited, prohibited in some cases or subject to conditions in the other countries whose rules we record (nothing changes for sale in France). Absence is not approval: several countries only allow the preservatives, UV filters and colorants on their lists, and the function of an ingredient in the product is not known. What is covered for each country.
| Country | Prohibited | Prohibited in some cases | Subject to conditions |
|---|---|---|---|
| United Kingdom | - | - | Salicylic Acid 2%, Cedrus Atlantic Bark Extract, Methylparaben, Propylparaben |
| Canada | - | - | Salicylic Acid 2% |
| Japan | - | - | Salicylic Acid 2% |
| South Korea | - | - | Salicylic Acid 2%, Methylparaben, Propylparaben |
| ASEAN | - | - | Salicylic Acid 2%, Methylparaben, Propylparaben |
| Taiwan | - | - | Salicylic Acid 2%, Methylparaben, Propylparaben |
| Brazil | - | - | Salicylic Acid 2%, Methylparaben, Propylparaben |
No prohibition or condition found in the recorded lists for: United States (federal), Washington State, California, China, Australia.
Ingredient by ingredient
The line under each name gives its rule in the European Union (legend below). Click a name for its page.
Hover over or tap a badge for its meaning.
Classified hazard (cancer, DNA, reproduction): Carcinogenic, mutagenic or toxic for reproduction under the CLPEU regulation that classifies chemicals by their hazards (EC No 1272/2008). Regulation, or identified endocrine disruptor. Irritation, allergy and environment: see “Who it concerns”.
| On the label | Glossary name | Rule in the European Union | Classified hazard (cancer, DNA, reproduction) |
|---|---|---|---|
| Salicylic Acid 2% | SALICYLIC ACID | Allowed with restrictions (Annex III) Preservative allowed under conditions (Annex V) Annex III, entry 98: products: (a) Rinse-off hair products (b) Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant (c) Body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant; maximum concentration: (a) 3.0% (b) 2.0% (c) 0.5% Annex V, entry 3: maximum concentration: Salicylic acid: 0.5% (acid) Salicylic acid salts: 0.5% (acid) | Toxic for reproduction: suspected effect (category 2, CLP classification) |
| Alcohol | ALCOHOL | No specific rule in the Cosmetics Regulation | none |
| Butylene Glycol | BUTYLENE GLYCOL | No specific rule in the Cosmetics Regulation | none |
| Capryloyl Glycine | CAPRYLOYL GLYCINE | No specific rule in the Cosmetics Regulation | none |
| Cedrus Atlantic Bark Extract spelling corrected | CEDRUS ATLANTICA BARK EXTRACT Certainty medium: one letter away from a glossary name (likely typo) | Allowed with restrictions (Annex III) | none |
| Cinnamomum Zeylanicum Bark Extract | CINNAMOMUM ZEYLANICUM BARK EXTRACT | No specific rule in the Cosmetics Regulation | none |
| Hexylene Glycol | HEXYLENE GLYCOL | No specific rule in the Cosmetics Regulation | none |
| Hydroxyethylcellulose | HYDROXYETHYLCELLULOSE | No specific rule in the Cosmetics Regulation | none |
| Methylparaben | METHYLPARABEN | Preservative allowed under conditions (Annex V) Annex V, entry 12: maximum concentration: 0.4% (as acid) for single ester 0.8% (as acid) for mixtures of esters | none |
| Portulica Oleracea Extract spelling corrected | PORTULACA OLERACEA EXTRACT Certainty medium: one letter away from a glossary name (likely typo) | No specific rule in the Cosmetics Regulation | none |
| PPG-2 Isoceth-20 Acetate | not recognised | Name not recognised in the European glossary | unknown |
| Propylene Glycol | PROPYLENE GLYCOL | No specific rule in the Cosmetics Regulation | none |
| Propylparaben | PROPYLPARABEN | Preservative allowed under conditions (Annex V) Annex V, entry 12 a: maximum concentration: - 0.14% (as acid) for the sum of the individual concentrations - 0.8% (as acid) for mixtures of substances mentioned in entry 12 and 12a, here the sum of the individual concentrations of butyl and propylparaben and their salts does not exceed 0.14% | none |
| Sarcosine | SARCOSINE | No specific rule in the Cosmetics Regulation | none |
| Sodium Citrate | SODIUM CITRATE | No specific rule in the Cosmetics Regulation | none |
| Water | WATER | No specific rule in the Cosmetics Regulation | none |
Product record
- Brand or trade name
- DOLLAR GENERAL ACNE SPOT MEDICATION
- Manufacturer
- DOLGENCORP, LLC
- Label date
- 10 July 2010
Label in the official openFDA API. This is the label date; the formula may have changed. Compare with the packaging.
List in the official revision dated (register: openFDA: US OTC product labels, analysed under European cosmetic rules).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “DOLLAR GENERAL ACNE SPOT MEDICATION”, https://compoatlas.com/en/cosmetics/united-states/87ee2144-bc3d-4578-b334-032e8c650b37-dollar-general-acne-spot-medication, updated 10 July 2010.